SCHEMBL5574087

SCHEMBL5574087

NC(=O)CC[C@H](N)C(=O)NC(N)=O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BLM P54132 2/20 0.56
ALOX15 P16050 1/20 0.56
PMP22 Q01453 1/20 0.56
KMT2A Q03164 1/20 0.56
DPP4 P27487 3/20 0.53
DPP8 Q6V1X1 3/20 0.53
DPP9 Q86TI2 3/20 0.53
SLC15A1 P46059 1/20 0.40
GRM8 O00222 1/20 0.37
GRM6 O15303 1/20 0.37
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
GSR P00390 1/20 0.37
CYP1A2 P05177 1/20 0.37
GRIK1 P39086 1/20 0.37
GRM5 P41594 1/20 0.37
GRIA1 P42261 1/20 0.37
GRIA2 P42262 1/20 0.37
GRIA3 P42263 1/20 0.37
SLC1A3 P43003 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28528076 1.00 BLM (0.56) BLMALOX15PMP22KMT2ADPP4
SCHEMBL8773315 0.91 BLM (0.60) BLMALOX15PMP22KMT2ADPP4
SCHEMBL5574084 0.85 GRM8 (0.56) BLMALOX15PMP22KMT2ADPP4
SCHEMBL31572013 0.85 BLM (0.59) BLMALOX15PMP22KMT2ADPP4
SCHEMBL5574080 0.85 GRM8 (0.56) BLMALOX15PMP22KMT2ADPP4
SCHEMBL3424069 0.82 DPP4 (0.57) BLMALOX15PMP22KMT2ADPP4
SCHEMBL29833669 0.80 BLM (0.58) BLMALOX15PMP22KMT2ADPP4
SCHEMBL288407 0.80 BLM (0.58) BLMALOX15PMP22KMT2ADPP4
SCHEMBL21447963 0.80 BLM (0.58) BLMALOX15PMP22KMT2ADPP4
SCHEMBL4321248 0.80 BLM (0.58) BLMALOX15PMP22KMT2ADPP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111295389-B Bioactive substance conjugate and preparation method and application thereof 四川科伦博泰生物医药股份有限公司 2021-10-22 CN claimed
EP-0708660-A1 PRODRUGS OF PROTEIN TYROSINE KINASE INHIBITORS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1996-05-01 EP claimed
WO-1995002420-A2 PRODRUGS OF PROTEIN TYROSINE KINASE INHIBITORS CANCER RESEARCH CAMPAIGN TECHNOLOGY LTD. (GB) 1995-01-26 WO claimed
CN-113453720-B Dual ligand drug conjugate and uses thereof 同宜医药(苏州)有限公司 2025-05-06 CN disclosed
CN-119031938-A Compounds and uses 同宜医药(苏州)有限公司 2024-11-26 CN disclosed
CN-113549127-A Vincristine and antibody conjugate thereof, preparation method and medical application thereof 上海翰森生物医药科技有限公司 2021-10-26 CN disclosed
CN-112341521-A Small molecule active compound and antibody conjugate thereof, preparation method and medical application thereof 上海翰森生物医药科技有限公司 2021-02-09 CN disclosed
EP-0711177-B1 IMPROVEMENTS RELATING TO THE PREPARATION OF PRODRUGS CANCER RES CAMPAIGN TECH (GB) 2007-05-09 EP disclosed
EP-0708660-B1 COMPOUNDS USEFUL FOR PREPARING PRODRUGS OF PROTEIN TYROSINE KINASE INHIBITORS CANCER RES CAMPAIGN TECH (GB) 2007-05-09 EP disclosed
US-5770731-A PROTECTING GROUPS, ANTIBODY DIRECTED ENZYME/PRODRUG THERAPY, ANTICARCINOGENIC AGENTS CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1998-06-23 US disclosed
US-5728868-A Prodrugs of protein tyrosine kinase inhibitors CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1998-03-17 US disclosed